ReviewNature reviews. Clinical oncology2026

Navigating the landscape of EGFR TKI resistance in EGFR-mutant NSCLC - mechanisms and evolving treatment approaches.

Jing Zhao et al.PubMed ↗Publisher ↗

No numbers read from the abstract.